If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalculus Vct Regulatory News (CLC)

Share Price Information for Calculus Vct (CLC)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
48.00
Ask:
58.50
Spread: 10.50 (21.875%)
Market Cap: £52.20m
CLC Live PriceLast checked at - London Stock Exchange

Intraday Calculus Vct Share Chart

Issue of Equity

5 Oct 2010 11:52

Investec Structured Products Calculus VCT plc

Issue of Equity

The Directors of Investec Structured Products Calculus VCT plc are pleased to announce an allotment on 5 October 2010 of 115,830 ordinary shares of 1p each ("Ordinary Shares") at an offer price of 103.6p per share, pursuant to the offer for subscription that opened on 20 September 2010 (the "Offer").

As set out in the prospectus, the offer price is based on an adjusted unaudited net asset value per Ordinary Share of 98.42p as at 1 October 2010, divided by 0.95 (to allow for offer costs of 5.0 per cent.), rounded up to the nearest 0.1p per share.

Application for the Ordinary Shares to be admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities has been made and it is expected that admission will take place on 6 October 2010.

Following these allotments the issued share capital of the Company is 3,983,747 Ordinary Shares.

For further enquiries please contact:

Gary Dale (Investec Structured Products)

Tel: 020 7597 4065 Email: gary.dale@investec.co.uk Susan McDonald (Calculus Capital) Tel: 0207 493 4940 Email: info@calculuscapital.com

5 October 2010

vendor
Date   Source Headline
11th Sep 202012:03 pmRNSIssue of Equity - Amendment
8th Sep 20201:01 pmRNSPublication of a Prospectus
8th Sep 202012:51 pmRNSPublication of a Prospectus
3rd Sep 20202:46 pmRNSIssue of Equity
31st Jul 202012:46 pmRNSDirector/ PDMR shareholding
3rd Jul 20204:42 pmRNSResult of AGM
3rd Jul 20204:09 pmRNSDirectorate Change
18th Jun 20204:45 pmRNSTransaction in Own Shares
17th Jun 20205:34 pmRNSNet Asset Value 31 May 2020
17th Jun 20205:07 pmRNSNet Asset Value 31 May 2020
27th May 20203:40 pmRNSAnnual Financial Report
21st May 20204:09 pmRNSDirector Declaration
3rd Apr 20204:15 pmRNSIssue of Equity
31st Mar 20202:18 pmRNSNet Asset Value(s) and Impact of Covid-19
19th Dec 20194:22 pmRNSNet Asset Value(s)
12th Dec 201911:29 amRNSIssue of Equity and Correction
18th Oct 20194:40 pmRNSHalf-year Report
24th Sep 20192:18 pmRNSPublication of a Prospectus
6th Sep 201911:22 amRNSIssue of Equity
4th Sep 20193:20 pmRNSNet Asset Value(s)
31st Jul 20192:48 pmRNSTransaction in Own Shares
4th Jul 20194:24 pmRNSResult of AGM
26th Jun 20192:25 pmRNSIssue of Equity
14th Jun 20199:52 amRNSNet Asset Value(s)
9th May 20195:49 pmRNSAnnual Financial Report - Replacement
9th May 20194:12 pmRNSAnnual Financial Report
5th Apr 20193:49 pmRNSIssue of Equity
28th Feb 201910:41 amRNSIssue of Equity
22nd Feb 20194:46 pmRNSNet Asset Value(s)
4th Feb 201910:02 amRNSDirectorate Change
24th Jan 201910:19 amRNSHolding(s) in Company
23rd Jan 201912:46 pmRNSIssue of Equity
16th Jan 20192:45 pmRNSNet Asset Value(s)
8th Jan 20193:49 pmRNSNet Asset Value(s)
18th Dec 201812:42 pmRNSDirector Declaration
13th Dec 20183:34 pmRNSDirectorate Change
6th Nov 201810:17 amRNSTransaction in Own Shares
23rd Oct 20184:32 pmRNSHalf-year Report
9th Oct 20183:21 pmRNSGM Statement
17th Sep 20184:33 pmRNSHolding(s) in Company
17th Sep 20184:33 pmRNSHolding(s) in Company
14th Sep 20187:00 amRNSPublication of a Prospectus
22nd Aug 20189:24 amRNSDirector Declaration
21st Aug 20184:54 pmRNSTransaction in Own Shares
16th Aug 20183:32 pmRNSNet Asset Value(s)
2nd Aug 20181:31 pmRNSIssue of Equity
19th Jul 20184:32 pmRNSNet Asset Value(s)
3rd Jul 201812:21 pmRNSResult of Meeting & Offer for subscription
19th Jun 20183:38 pmRNSNet Asset Value(s)
22nd May 20184:52 pmRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.